Please login to the form below

Not currently logged in
Email:
Password:

Prosena Therapeutics

This page shows the latest Prosena Therapeutics news and features for those working in and with pharma, biotech and healthcare.

GSK's muscular dystrophy drug 'a breakthrough' says FDA

GSK's muscular dystrophy drug 'a breakthrough' says FDA

Holland-based Prosensa and GSK are currently in a race with Sarepta Therapeutics of the US (formerly AVI BioPharma) to bring an exon 51-skipping drug for DMD to market, and

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest appointments

  • Larry Bell joins Dutch biopharma Prosensa Larry Bell joins Dutch biopharma Prosensa

    Dutch biopharmaceutical company Prosensa Therapeutics has appointed Larry Bell as head of global regulatory affairs. ... For his new role at Prosensa, which focuses on RNA-modulating therapeutics for rare diseases with high unmet need, Bell will be based

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics